News
Eli Lilly's stock dipped after drug trial results, but strong Q2 2025 earnings and market position make it a strong buy. Read ...
13h
MarketBeat on MSNTrump GLP-1 Pilot Program Could Boost Novo Nordisk & Eli LillyThis week, drugmakers had a scare when President Trump threatened to levy tariffs of up to 250% on imported pharmaceuticals.
A London-based consultant plastic and cosmetic surgeon, has warned of a mistake those on weight loss jabs can make that could ...
Hyderabad: Sales of weight-loss drugs Wegovy by Danish pharmaceutical giant Novo Nordisk and Mounjaro by U.S.-based Eli Lilly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results